Brief recommendations on the management of adult patients with familial hypercholesterolemia during the COVID-19 pandemic
Maciej Banach1,2,3, Peter E. Penson4, Zlatko Fras5, Michal Vrablik6, Daniel Pella7, Željko Reiner8, Seyed Mohammad Nabavi9, Amirhossein Sahebkar10,11,12, Meral Kayikcioglu13, Magdalena Daccord14
1Department of Hypertension, Chair of Nephrology and Hypertension, Medical University of Lodz, Poland
2Polish Mother’s Memorial Hospital Research Institute (PMMHRI), Lodz, Poland
3Cardiovascular Research Centre, University of Zielona Gora, Zielona Gora, Poland
4School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Liverpool, UK
5Division of Medicine, Centre for Preventive Cardiology, University Medical Centre Ljubljana, Medical Faculty, University of Ljubljana, Ljubljana, Slovenia
6Third Department of Internal Medicine, First Faculty of Medicine, Charles University and General Faculty Hospital in Prague, Prague, Czech Republic
7Department of Cardiology of the East Slovak Institute of Cardiovascular Disease and Faculty of Medicine PJ Safarik University, Kosice, Slovak Republic
8Department of Internal Diseases, University Hospital Center Zagreb School of Medicine, Zagreb University, Zagreb, Croatia
9Baqiyatallah Hospital, Baqiyatallah University of Medical Sciences, Tehran, Iran
10Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran
11Neurogenic Inflammation Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
12School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran
13Department of Cardiology, Ege Üniversitesi School of Medicine, Izmir, Turkey
14FH Europe, Europe
Tài liệu tham khảo
Thông tin
Thông tin xuất bản
Pharmacological Research
Tập 158
104891
Thông tin tác giả